Quantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
Open Access
- 30 April 2026
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 49 (5) , e70285
Abstract
Objective: To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions. Methods: From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled. All participants underwent two‐dimensional echocardiography and MCE. Myocardial perfusion parameters—peak intensity ( A ‐value), wash‐in slope ( β ‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model. Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy. Results: Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity ( A ‐value) and MBF ( p < 0.05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate (β ‐value), and MBF ( p < 0.05). Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments ( p < 0.05). Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower A ‐value and MBF than the septum ( p < 0.05). In contrast, pathological hypertrophy showed reduced A ‐value but increased β ‐value in the free wall ( p < 0.05). ROC curve analysis identified an optimal cutoff value of A > 8.13 dB (AUC = 0.904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy. Conclusion: MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients. The A value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.Keywords
This publication has 28 references indexed in Scilit:
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsArchives of Toxicology, 2015
- Hypertension impairs myocardial blood perfusion reserve in subjects without regional myocardial ischemiaHypertension Research, 2010
- The Effects of Medications on Myocardial PerfusionJACC, 2008
- Myocardial contrast echocardiography: another discriminator of physiological and pathological left ventricular hypertrophy?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006
- The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humansEuropean Heart Journal, 2006
- The quantification of absolute myocardial perfusion in humans by contrast echocardiographyJACC, 2005
- Myocardial Perfusion During Long-Term Angiotensin-Converting Enzyme Inhibition or β-Blockade in Patients With Essential HypertensionHypertension, 2004
- Coronary microcirculation into different models of left ventricular hypertrophy—hypertensive and athlete's heart: a contrast echocardiographic studyJournal of Human Hypertension, 2003
- Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous InfusionCirculation, 1998
- Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertensionJACC, 1992